1,000
Participants
Start Date
March 11, 2008
Primary Completion Date
March 31, 2026
Study Completion Date
March 31, 2026
Questionnaires
The survey will be administered by mail or telephone interview, based upon the participant preference. The survey has been adapted from the 2008 questionnaire being administered through the CCSS (11); it has been supplemented with questions addressing areas of interest specific to the retinoblastoma survivor population (eg, validated instruments that assess visual impairment).
RECRUITING
Memorial Sloan Kettering Cancer Center, New York
National Cancer Institute (NCI)
NIH
St. Jude Children's Research Hospital
OTHER
Memorial Sloan Kettering Cancer Center
OTHER